63 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6446
NT$1,195.001.7%188.4%NT$492.6bNT$1,073.3183.138.3%0.08%Pharmaceuticals & Biotech
6919
NT$102.00-4.2%-25.3%NT$158.7bNT$240.004173.3119.9%n/aPharmaceuticals & Biotech
6472
NT$396.501.0%-43.0%NT$50.5bNT$673.5530.061.1%2.5%Pharmaceuticals & Biotech
1795
NT$184.00-2.6%-18.4%NT$48.4bNT$367.0012.627.7%1.4%Pharmaceuticals & Biotech
4123
NT$38.402.4%8.5%NT$28.7bn/a2.7n/a4.5%Pharmaceuticals & Biotech
4728
NT$383.000.8%-6.1%NT$20.9bn/a28.8n/a3.2%Pharmaceuticals & Biotech
4105
NT$76.80-1.7%0%NT$19.1bNT$92.0011.9n/a5.9%Pharmaceuticals & Biotech
6620
NT$89.003.7%6.2%NT$14.8bNT$100.0019.06.9%2.2%Pharmaceuticals & Biotech
3705
NT$53.80-2.2%-11.7%NT$14.3bn/a18.1n/a5.6%Pharmaceuticals & Biotech
4169
New
NT$223.00-12.5%220.4%NT$13.2bNT$194.0018.7116.9%0.2%Pharmaceuticals & Biotech
1720
NT$57.40-0.7%9.8%NT$11.3bn/a11.7n/a3.2%Pharmaceuticals & Biotech
6550
NT$11.90-3.3%-68.4%NT$10.2bn/a147.7n/an/aPharmaceuticals & Biotech
4162
NT$65.802.3%-14.7%NT$9.5bn/a22.4n/a3.0%Pharmaceuticals & Biotech
6976
NT$12.45-3.9%-19.4%NT$7.4bn/a39225.4n/an/aPharmaceuticals & Biotech
4142
NT$17.101.2%-3.1%NT$7.2bn/a5.1n/a0%Pharmaceuticals & Biotech
1734
NT$31.553.4%10.8%NT$6.4bn/a19.4n/a3.2%Pharmaceuticals & Biotech
4167
New
NT$19.10-0.5%8.2%NT$6.3bn/a26.2n/a4.2%Pharmaceuticals & Biotech
4746
NT$51.600.4%-24.2%NT$6.2bn/a18.3n/a5.8%Pharmaceuticals & Biotech
4166
New
NT$25.55-4.1%-30.3%NT$5.7bn/a29.0n/an/aPharmaceuticals & Biotech
4726
NT$24.952.5%-34.4%NT$5.2bn/a6.3n/an/aPharmaceuticals & Biotech
1799
NT$39.3021.5%-14.2%NT$4.9bn/a7.2n/an/aPharmaceuticals & Biotech
3716
NT$33.30-2.5%-1.5%NT$4.9bn/a12.9n/a3.0%Pharmaceuticals & Biotech
3176
NT$33.40-1.2%6.7%NT$4.7bn/a3.5n/an/aPharmaceuticals & Biotech
6875
NT$35.300%-11.0%NT$4.6bn/a66.0n/an/aPharmaceuticals & Biotech
Page 1 of 2